Background: Cardiac resynchronization therapy (CRT) produces clinical benefit in heart failure (HF) patients (pts) with intraventricular conduction delay. Previous studies excluded pts who already had a pacing device. In this study, pts with denovo (DN) CRT were compared to those undergoing upgrade (UP) to CRT from standard pacing.